| 1 |
Deniz Tekin E. Investigation of the effects of N-Acetylglucosamine on the stability of the spike protein in SARS-CoV-2 by molecular dynamics simulations. Comput Theor Chem 2023;1222:114049. [PMID: 36743995 DOI: 10.1016/j.comptc.2023.114049] [Reference Citation Analysis]
|
| 2 |
Avelar M, Pedraza-González L, Sinicropi A, Flores-Morales V. Triterpene Derivatives as Potential Inhibitors of the RBD Spike Protein from SARS-CoV-2: An In Silico Approach. Molecules 2023;28. [PMID: 36903578 DOI: 10.3390/molecules28052333] [Reference Citation Analysis]
|
| 3 |
Yang T, Wang SC, Ye L, Maimaitiyiming Y, Naranmandura H. Targeting viral proteins for restraining SARS-CoV-2: focusing lens on viral proteins beyond spike for discovering new drug targets. Expert Opin Drug Discov 2023;18:247-68. [PMID: 36723288 DOI: 10.1080/17460441.2023.2175812] [Reference Citation Analysis]
|
| 4 |
Singh R, Purohit R. Multi-target approach against SARS-CoV-2 by stone apple molecules: A master key to drug design. Phytother Res 2023. [PMID: 36786431 DOI: 10.1002/ptr.7772] [Reference Citation Analysis]
|
| 5 |
Xiang Y, Zhai G, Li Y, Wang M, Chen X, Wang R, Xie H, Zhang W, Ge G, Zhang Q, Xu Y, Caflisch A, Xu J, Chen H, Chen L. Ginkgolic acids inhibit SARS-CoV-2 and its variants by blocking the spike protein/ACE2 interplay. Int J Biol Macromol 2023;226:780-92. [PMID: 36521705 DOI: 10.1016/j.ijbiomac.2022.12.057] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 6 |
Ngo ST, Nguyen TH, Tung NT, Vu VV, Pham MQ, Mai BK. Characterizing the ligand-binding affinity toward SARS-CoV-2 Mpro via physics- and knowledge-based approaches. Phys Chem Chem Phys 2022. [PMID: 36449268 DOI: 10.1039/d2cp04476e] [Reference Citation Analysis]
|
| 7 |
da Cruz Freire JE, Júnior JEM, Pinheiro DP, da Cruz Paiva Lima GE, do Amaral CL, Veras VR, Madeira MP, Freire EBL, Ozório RG, Fernandes VO, Montenegro APDR, Montenegro RC, Colares JKB, Júnior RMM. Evaluation of the anti-diabetic drug sitagliptin as a novel attenuate to SARS-CoV-2 evidence-based in silico: molecular docking and molecular dynamics. 3 Biotech 2022;12:344. [DOI: 10.1007/s13205-022-03406-w] [Reference Citation Analysis]
|
| 8 |
Singh R, Bhardwaj VK, Purohit R. Inhibition of nonstructural protein 15 of SARS-CoV-2 by golden spice: A computational insight. Cell Biochem Funct 2022;40:926-34. [PMID: 36203381 DOI: 10.1002/cbf.3753] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 9 |
Esther Rubavathy SM, Palanisamy K, Priyankha S, Thilagavathi R, Prakash M, Selvam C. Discovery of novel HDAC8 inhibitors from natural compounds by in silico high throughput screening. Journal of Biomolecular Structure and Dynamics 2022. [DOI: 10.1080/07391102.2022.2142668] [Reference Citation Analysis]
|
| 10 |
Prabhu NB, Vinay CM, Satyamoorthy K, Rai PS. Pharmacogenomics deliberations of 2-deoxy-d-glucose in the treatment of COVID-19 disease: an in silico approach. 3 Biotech 2022;12. [DOI: 10.1007/s13205-022-03363-4] [Reference Citation Analysis]
|
| 11 |
Rajan M, Prabhakaran S, Prusty JS, Chauhan N, Gupta P, Kumar A. Phytochemicals of Cocculus hirsutus deciphered SARS-CoV-2 inhibition by targeting main proteases in molecular docking, simulation, and pharmacological analyses. J Biomol Struct Dyn 2022;:1-15. [PMID: 36099182 DOI: 10.1080/07391102.2022.2121758] [Reference Citation Analysis]
|
| 12 |
Gentile D, Coco A, Patamia V, Zagni C, Floresta G, Rescifina A. Targeting the SARS-CoV-2 HR1 with Small Molecules as Inhibitors of the Fusion Process. Int J Mol Sci 2022;23:10067. [PMID: 36077465 DOI: 10.3390/ijms231710067] [Reference Citation Analysis]
|
| 13 |
Kumar A, Rathi E, Kini SG. Computational design of a broad-spectrum multi-epitope vaccine candidate against seven strains of human coronaviruses. 3 Biotech 2022;12:240. [PMID: 36003896 DOI: 10.1007/s13205-022-03286-0] [Reference Citation Analysis]
|
| 14 |
Singh S, Banavath HN, Godara P, Naik B, Srivastava V, Prusty D. Identification of antiviral peptide inhibitors for receptor binding domain of SARS-CoV-2 omicron and its sub-variants: an in-silico approach. 3 Biotech 2022;12:198. [PMID: 35923684 DOI: 10.1007/s13205-022-03258-4] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 15 |
Sherwani S, Rajendrasozhan S, Khan MWA, Saleem M, Khan M, Khan S, Raafat M, Othman Alqahtani F. Pharmacological Profile of Nigella sativa Seeds in Combating COVID-19 through In-Vitro and Molecular Docking Studies. Processes 2022;10:1346. [DOI: 10.3390/pr10071346] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
